Sun Pharmaceutical Industries Q1 Results

BSE: 524715 | NSE: SUNPHARMA | ISIN: INE044A01036 | Sector: Biotechnology & Drugs

1,191.40 -5.00 (-0.42%)Updated : 28 Nov 2023

Fiscal Period	2024
Period End Date	Jun 23
Revenue	11940.84
Total Revenue	11940.84
Costof Revenue Total	2758.17
Gross Profit	9182.67
Selling/ General/ Admin Expenses Total	2402.04
Depreciation/ Amortization	651.32
Unusual Expense( Income)	322.87
Other Operating Expenses Total	3450.90
Total Operating Expense	9585.30
Operating Income	2355.54
Interest Inc( Exp) Net- Non- Op Total	-788.40
Other Net	204.44
Net Income Before Taxes	2481.14
Provisionfor Income Taxes	468.10
Net Income After Taxes	2013.04
Minority Interest	16.89
Equity In Affiliates	-73.90
Net Income Before Extra Items	2022.54
Net Income	2022.54
Income Availableto Com Excl Extra Ord	2022.54
Income Availableto Com Incl Extra Ord	2022.54
Diluted Net Income	2022.54
Diluted Weighted Average Shares	240.78
Diluted EPS Excluding Extra Ord Items	8.40
DPS- Common Stock Primary Issue	0.00
Diluted Normalized EPS	9.49